Literature DB >> 23900688

Citric acid-γ-cyclodextrin crosslinked oligomers as carriers for doxorubicin delivery.

Resmi Anand1, Milo Malanga, Ilse Manet, Francesco Manoli, Kata Tuza, Ahmet Aykaç, C Ladavière, Eva Fenyvesi, Antonio Vargas-Berenguel, Ruxandra Gref, Sandra Monti.   

Abstract

Two citric acid crosslinked γ-cyclodextrin oligomers (pγ-CyD) with a MW of 21-33 kDa and 10-15 γ-CyD units per molecule were prepared by following green chemistry methods and were fully characterized. The non-covalent association of doxorubicin (DOX) with these macromolecules was investigated in neutral aqueous medium by means of circular dichroism (CD), UV-vis absorption and fluorescence. Global analysis of multiwavelength spectroscopic CD and fluorescence titration data, taking into account the DOX monomer-dimer equilibrium, evidenced the formation of 1 : 1 and 1 : 2 pγ-CyD unit-DOX complexes. The binding constants are 1-2 orders of magnitude higher than those obtained for γ-CyD and depend on the characteristics of the oligomer batch used. The concentration profiles of the species in solution evidence the progressive monomerization of DOX with increasing oligomer concentration. Confocal fluorescence imaging and spectral imaging showed a similar drug distribution within the MCF-7 cell line incubated with either DOX complexed to pγ-CyD or free DOX. In both cases DOX is taken up into the cell nucleus without any degradation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23900688     DOI: 10.1039/c3pp50169h

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  9 in total

1.  Cyclodextrin polymers decorated with RGD peptide as delivery systems for targeted anti-cancer chemotherapy.

Authors:  Maurizio Viale; Rita Tosto; Valentina Giglio; Giuseppe Pappalardo; Valentina Oliveri; Irena Maric; Maria Addolorata Mariggiò; Graziella Vecchio
Journal:  Invest New Drugs       Date:  2018-12-17       Impact factor: 3.850

2.  New doxorubicin nanocarriers based on cyclodextrins.

Authors:  Maurizio Viale; Valentina Giglio; Massimiliano Monticone; Irena Maric; Giovanni Lentini; Mattia Rocco; Graziella Vecchio
Journal:  Invest New Drugs       Date:  2017-04-04       Impact factor: 3.850

Review 3.  Citric Acid: A Multifunctional Pharmaceutical Excipient.

Authors:  Maria Lambros; Thac Henry Tran; Qinqin Fei; Mike Nicolaou
Journal:  Pharmaceutics       Date:  2022-04-30       Impact factor: 6.525

4.  Cyclodextrin polymers as nanocarriers for sorafenib.

Authors:  Valentina Giglio; Maurizio Viale; Vittorio Bertone; Irena Maric; Rita Vaccarone; Graziella Vecchio
Journal:  Invest New Drugs       Date:  2017-11-08       Impact factor: 3.850

5.  A "green" strategy to construct non-covalent, stable and bioactive coatings on porous MOF nanoparticles.

Authors:  V Agostoni; P Horcajada; M Noiray; M Malanga; A Aykaç; L Jicsinszky; A Vargas-Berenguel; N Semiramoth; S Daoud-Mahammed; V Nicolas; C Martineau; F Taulelle; J Vigneron; A Etcheberry; C Serre; R Gref
Journal:  Sci Rep       Date:  2015-01-21       Impact factor: 4.379

6.  Adsorption of Paraquat by Poly(Vinyl Alcohol)-Cyclodextrin Nanosponges.

Authors:  Ekkachai Martwong; Santi Chuetor; Jatupol Junthip
Journal:  Polymers (Basel)       Date:  2021-11-25       Impact factor: 4.329

7.  Controllable drug uptake and nongenomic response through estrogen-anchored cyclodextrin drug complex.

Authors:  Juan-Juan Yin; Stepan P Shumyak; Christopher Burgess; Zhi-Wei Zhou; Zhi-Xu He; Xue-Ji Zhang; Shu-Ting Pan; Tian-Xin Yang; Wei Duan; Jia-Xuan Qiu; Shu-Feng Zhou
Journal:  Int J Nanomedicine       Date:  2015-07-27

8.  Exploring Charged Polymeric Cyclodextrins for Biomedical Applications.

Authors:  Noemi Bognanni; Francesco Bellia; Maurizio Viale; Nadia Bertola; Graziella Vecchio
Journal:  Molecules       Date:  2021-03-19       Impact factor: 4.411

9.  Covalently Functionalized Carbon Nano-Onions Integrated Gelatin Methacryloyl Nanocomposite Hydrogel Containing γ-Cyclodextrin as Drug Carrier for High-Performance pH-Triggered Drug Release.

Authors:  Narsimha Mamidi; Ramiro Manuel Velasco Delgadillo; Enrique V Barrera
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.